EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Trimetazidine: Activating AMPK Signal to Ameliorate Coronary Microcirculation Dysfunction after Myocardial Infarction

Xiaolong Qu, Pan Yang, Li Jiao, Yuehui Yin

Frontiers in Bioscience-Landmark · 2025

DOI: 10.31083/fbl25565 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2025. Verfasst von Xiaolong Qu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, 401336 Chongqing, China. Hauptthemen laut MEDLINE: Trimetazidine, AMP-Activated Protein Kinases, Myocardial Infarction, Microcirculation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Myocardial ischemia-reperfusion (I/R) injury and coronary microcirculation dysfunction (CMD) are observed in patients with myocardial infarction after vascular recanalization. The antianginal drug trimetazidine has been demonstrated to exert a protective effect in myocardial ischemia-reperfusion injury.

Objectives

This study aimed to investigate the role of trimetazidine in endothelial cell dysfunction caused by myocardial I/R injury and thus improve coronary microcirculation.

Methods

The myocardial I/R mouse model was established, and trimetazidine was administered for 7 days before myocardial I/R model establishment. Echocardiography, 2,3,5-triphenyltetrazolium chloride (TTC) staining, hematoxylin-eosin (H&E) staining, and thioflavin S staining were applied to assess myocardial injury and microvascular function. Additionally, the oxygen-glucose deprivation/reperfusion (OGD/R) model was developed in endothelial cells to simulate myocardial I/R injury in vitro. Griess reaction method, immunofluorescence, and western blotting (WB) were employed to detect the expressions of nitric oxide (NO), platelet endothelial cell adhesion molecule-1 (CD31) and vascular endothelial (VE)-cadherin, zonula occludens protein 1 (ZO-1), occludin, vascular endothelial growth factor (VEGF) and adenosine monophosphate (AMP)-activated protein kinase (AMPK) signaling-related proteins in endothelial cells and mouse cardiomyocytes. AMPK pathway inhibitor compound C was used for further mechanism validation.

Results

Our research demonstrated that trimetazidine can alleviate myocardial pathological injury and cardiac function injury during myocardial I/R. Trimetazidine was observed to improve microvascular reflux phenomenon and microvascular function and barrier injury in myocardial I/R and OGD/R models. Additionally, the expressions of AMPK signal-related proteins were found to be inhibited in myocardial I/R and OGD/R models, which were then activated in mice administered trimetazidine. However, the effects of trimetazidine on endothelial cell function and barrier damage were attenuated after co-treatment with compound C and trimetazidine.

Conclusion

Trimetazidine ameliorated myocardial I/R-induced CMD by activating AMPK signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TrimetazidineAMP-Activated Protein KinasesMyocardial InfarctionMicrocirculationMyocardial Reperfusion InjuryCoronary CirculationVasodilator AgentsAnimalsMiceSignal TransductionMaleMice, Inbred C57BLDisease Models, AnimalNitric OxideEndothelial CellsCoronary VesselsPlatelet Endothelial Cell Adhesion Molecule-1

Stichwörter der Autor:innen

AMPK signalcoronary microcirculation dysfunctionmyocardial infarctiontrimetazidine

Substanzen

TrimetazidineAMP-Activated Protein KinasesNitric OxideVasodilator AgentsPlatelet Endothelial Cell Adhesion Molecule-1

Autor:innen und Institutionen

  • Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, 401336 Chongqing, China.
  • Department of Cardiovascular Medicine, Southwest Hospital, Army Medical University, 400038 Chongqing, China.
  • Emergency Department, The Second Affiliated Hospital of Chongqing Medical University, 401336 Chongqing, China.
  • Department of High Altitude Physiology and Pathology, College of High Altitude Military Medicine, Army Military Medical University, 400037 Chongqing, China.

Zitieren

APA

Qu, X., Yang, P., Jiao, L., & Yin, Y. (2025). Trimetazidine: Activating AMPK Signal to Ameliorate Coronary Microcirculation Dysfunction after Myocardial Infarction. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl25565

Vancouver

Qu X, Yang P, Jiao L, Yin Y. Trimetazidine: Activating AMPK Signal to Ameliorate Coronary Microcirculation Dysfunction after Myocardial Infarction. Frontiers in Bioscience-Landmark. 2025. doi:10.31083/fbl25565

BibTeX
@article{Qu2025,
  author = {Qu, Xiaolong and Yang, Pan and Jiao, Li and Yin, Yuehui},
  title = {Trimetazidine: Activating AMPK Signal to Ameliorate Coronary Microcirculation Dysfunction after Myocardial Infarction},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2025},
  doi = {10.31083/fbl25565}
}
Kostenlos starten →